Amgen obtains United States patent.(polypeptide patent)(Brief Article)

Amgen, Inc. (Thousand Oaks, CA) has patented polypeptides which bind to one or more EPH-like receptors, particularly the HEK4 receptor. The polypeptides are designated HEK4 …